Latest Samsara BioCapital, LLC Stock Portfolio
Samsara BioCapital, LLC Performance:
2024 Q4: 38.8%YTD: 14.92%2023: 20.78%
Performance for 2024 Q4 is 38.8%, and YTD is 14.92%, and 2023 is 20.78%.
About Samsara BioCapital, LLC and 13F Hedge Fund Stock Holdings
Samsara BioCapital, LLC is a hedge fund based in PALO ALTO, CA. On 26-Apr-2023, the fund reported that it had an AUM (Regulated Assets under Management) of $1.4 Billions. In it's latest 13F Holdings report, Samsara BioCapital, LLC reported an equity portfolio of $728.6 Millions as of 31 Dec, 2024.
The top stock holdings of Samsara BioCapital, LLC are SRRK, , . The fund has invested 33.3% of it's portfolio in SCHOLAR ROCK HLDG CORP and 8.7% of portfolio in CARGO THERAPEUTICS INC.
The fund managers got completely rid off SYROS PHARMACEUTICALS INC (SYRS), IO BIOTECH INC (IOBT) and BICARA THERAPEUTICS INC stocks. They significantly reduced their stock positions in HILLEVAX INC (HLVX), JANUX THERAPEUTICS INC (JANX) and VERONA PHARMA PLC (VRNA). Samsara BioCapital, LLC opened new stock positions in SEPTERNA INC and CURIS INC (CRIS). The fund showed a lot of confidence in some stocks as they added substantially to ACLARIS THERAPEUTICS INC (ACRS) and NEUROGENE INC.
The top stock holdings of Samsara BioCapital, LLC are SRRK, , . The fund has invested 33.3% of it's portfolio in SCHOLAR ROCK HLDG CORP and 8.7% of portfolio in CARGO THERAPEUTICS INC.
The fund managers got completely rid off SYROS PHARMACEUTICALS INC (SYRS), IO BIOTECH INC (IOBT) and BICARA THERAPEUTICS INC stocks. They significantly reduced their stock positions in HILLEVAX INC (HLVX), JANUX THERAPEUTICS INC (JANX) and VERONA PHARMA PLC (VRNA). Samsara BioCapital, LLC opened new stock positions in SEPTERNA INC and CURIS INC (CRIS). The fund showed a lot of confidence in some stocks as they added substantially to ACLARIS THERAPEUTICS INC (ACRS) and NEUROGENE INC.
Samsara BioCapital, LLC Annual Return Estimates Vs S&P 500
Our best estimate is that Samsara BioCapital, LLC made a return of 38.8% in the last quarter. In trailing 12 months, it's portfolio return was 14.92%.
New Buys
| Ticker | $ Bought |
|---|---|
| septerna inc | 63,399,100 |
| upstream bio inc | 36,449,900 |
| palvella therapeutics inc ne | 8,153,830 |
| onkure therapeutics inc | 7,087,730 |
| curis inc | 606,541 |
New stocks bought by Samsara BioCapital, LLC
Additions
| Ticker | % Inc. |
|---|---|
| aclaris therapeutics inc | 242 |
| neurogene inc | 35.44 |
Additions to existing portfolio by Samsara BioCapital, LLC
Reductions
| Ticker | % Reduced |
|---|---|
| hillevax inc | -50.00 |
| janux therapeutics inc | -50.00 |
| verona pharma plc | -49.99 |
| lyra therapeutics inc | -29.3 |
| arcellx inc | -28.28 |
| prime medicine inc | -25.00 |
| lenz therapeutics inc | -18.33 |
| scholar rock hldg corp | -17.32 |
Samsara BioCapital, LLC reduced stake in above stock
Sold off
| Ticker | $ Sold |
|---|---|
| io biotech inc | -3,822,020 |
| syros pharmaceuticals inc | -3,840,820 |
| viracta therapeutics inc | -159,599 |
| bicara therapeutics inc | -891,450 |
Samsara BioCapital, LLC got rid off the above stocks
Sector Distribution
Samsara BioCapital, LLC has about 53.2% of it's holdings in Others sector.
| Sector | % |
|---|---|
| Others | 53.2 |
| Healthcare | 46.8 |
Market Cap. Distribution
Samsara BioCapital, LLC has about 0% of it's portfolio invested in the large-cap and mega-cap stocks.
| Category | % |
|---|---|
| UNALLOCATED | 53.2 |
| SMALL-CAP | 35.9 |
| MICRO-CAP | 5.6 |
| MID-CAP | 5.1 |
Stocks belong to which Index?
About 43.5% of the stocks held by Samsara BioCapital, LLC either belong to S&P 500 or RUSSELL 2000 index.
| Index | % |
|---|---|
| Others | 56.5 |
| RUSSELL 2000 | 43.5 |
Samsara BioCapital, LLC Holdings Map
This heatmap illustrates the top 50 positions within the fund's portfolio.
Current Stock Holdings of Samsara BioCapital, LLC
Samsara BioCapital, LLC has 43 stocks in it's portfolio. About 81.8% of the portfolio is in top 10 stocks. ELYM proved to be the most loss making stock for the portfolio. SRRK was the most profitable stock for Samsara BioCapital, LLC last quarter.
Last Reported on: 14 Feb, 2025| Ticker | Namesorted ascending | % Portfolio | Shares Held | $ Value | Type | % Change | Options | |
|---|---|---|---|---|---|---|---|---|
| ACLX | arcellx inc | 2.67 | 253,641 | 19,451,700 | reduced | -28.28 | ||
| ACRS | aclaris therapeutics inc | 0.81 | 2,385,060 | 5,914,950 | added | 242 | ||
| ALLK | allakos inc | 0.03 | 172,089 | 208,228 | unchanged | 0.00 | ||
| ALVR | allovir inc | 0.00 | 3,579 | 34,581 | unchanged | 0.00 | ||
| BOLT | bolt biotherapeutics inc | 0.08 | 1,049,150 | 561,402 | unchanged | 0.00 | ||
| CRIS | curis inc | 0.08 | 198,216 | 606,541 | new | |||
| DAWN | day one biopharmaceuticals i | 0.26 | 147,319 | 1,866,530 | unchanged | 0.00 | ||
| ELYM | climb bio inc | 0.64 | 2,609,110 | 4,696,400 | unchanged | 0.00 | ||
| GOSS | gossamer bio inc | 0.76 | 6,130,270 | 5,545,440 | unchanged | 0.00 | ||
| HLVX | hillevax inc | 0.11 | 399,637 | 827,249 | reduced | -50.00 | ||
| INZY | inozyme pharma inc | 0.59 | 1,562,500 | 4,328,120 | unchanged | 0.00 | ||
| IOBT | io biotech inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| JANX | janux therapeutics inc | 0.08 | 11,263 | 603,021 | reduced | -50.00 | ||
| JSPR | jasper therapeutics inc | 1.72 | 584,642 | 12,499,600 | unchanged | 0.00 | ||
| KRON | kronos bio inc | 0.01 | 78,131 | 74,224 | unchanged | 0.00 | ||
| LPTX | leap therapeutics inc | 0.96 | 2,442,350 | 7,021,760 | unchanged | 0.00 | ||
| LYRA | lyra therapeutics inc | 0.06 | 1,965,690 | 405,718 | reduced | -29.3 | ||
| NKTX | nkarta inc | 1.29 | 3,768,040 | 9,382,410 | unchanged | 0.00 | ||
| NUVB | nuvation bio inc | 0.00 | 133,333 | 30,667 | unchanged | 0.00 | ||
| RYTM | rhythm pharmaceuticals inc | 1.33 | 172,647 | 9,664,780 | unchanged | 0.00 | ||